Q1 2024 Pharming Group NV Earnings Call Transcript
Welcome, ladies and gentlemen, to this first-quarter results conference. I'm here with my -- next slide, please -- I'm here with my three colleagues in order of speaking, Stephen Toor, our Chief Commercial Officer, who is joining us from our New Jersey office; Dr. Anurag Relan, our Chief Medical Officer, joining us from our US office as well; and Jeroen Wakkerman, our Chief Financial Officer, who is based with me here in Leiden.
Before I do that, I would like to point out to next slide, please, number three, that is the forward-looking statement slide. So we will be making forward-looking statements today in our presentation, and those are based upon our current plans and your insights of the -- and situations of the current market circumstances. And of course, actual results may differ from these forward-looking statements. So you cannot necessarily rely on those.
So having said that, I would like to go to slide number 4 and maybe even onwards to slide number 5, because you have seen my picture already.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
